Novavax Inc. stock underperforms Wednesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Wednesday when compared to competitors | news.google.com • |
Shah Capital Management Acquires 1,544,263 Shares of Novavax, Inc. (NASDAQ:NVAX) | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | 1.82 | 0.99 | -0.83 | -45.60% |
2024-05-10 | 2024-03 | -1.04 | -1.05 | -0.01 | -0.96% |
2024-02-28 | 2023-12 | -0.49 | -1.44 | -0.95 | -193.88% |
2023-11-09 | 2023-09 | -1.82 | -1.26 | 0.56 | 30.77% |
2023-08-08 | 2023-06 | -1.24 | 0.58 | 1.82 | 146.77% |
2023-05-09 | 2023-03 | -3.38 | -3.41 | -0.03 | -0.89% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-08 | B. Riley Securities | Upgrade | Neutral | Buy |
2023-05-09 | HC Wainwright & Co. | Upgrade | Buy | |
2023-02-28 | B. Riley Securities | Downgrade | Buy | Neutral |
2023-02-12 | HC Wainwright & Co. | Upgrade | Buy | |
2023-01-01 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-06-11 | ALTON GREGG H | Director | 10.47K | Conversion of Exercise of derivative security |
2024-06-11 | DOUGLAS RICHARD H | Director | 43.92K | Conversion of Exercise of derivative security |
2024-06-16 | DUBOVSKY FILIP | Officer | 66.61K | Sale |
2024-08-15 | KELLY JAMES PATRICK | Chief Financial Officer | 14.43K | Conversion of Exercise of derivative security |
2024-06-11 | KING RACHEL K | Director | 18.92K | Conversion of Exercise of derivative security |
2024-06-11 | MCGLYNN MARGARET G | Director | 10.47K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | State Street Corporation | 11.68M | 86.78M | 12.37% |
2023-06-29 | Vanguard Group Inc | 10.57M | 78.55M | 11.20% |
2023-06-29 | Blackrock Inc. | 6.99M | 51.97M | 7.41% |
2023-09-29 | Shah Capital Management | 6.33M | 45.83M | 6.71% |
2023-06-29 | Bank of America Corporation | 2.18M | 16.23M | 2.31% |
2023-06-29 | Morgan Stanley | 2.08M | 15.46M | 2.20% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 9.38M | 75.07M | 9.94% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.64M | 19.60M | 2.79% |
2023-06-29 | Vanguard Small-Cap Index Fund | 2.23M | 16.56M | 2.36% |
2023-08-30 | iShares Russell 2000 ETF | 2.01M | 16.10M | 2.13% |
2023-06-29 | Vanguard Small-Cap Growth Index Fund | 1.28M | 9.48M | 1.35% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.21M | 8.98M | 1.28% |
Split | Date |
---|---|
1 : 20 | 2019-05-10 |
-
Holly crap. The nasdaq is 3.4% up and we are only 4%. What is going on?
-
MRNA is 15% up. We need to the FDA approval to jump up to the 15%
-
Nasdaq is back up to 2.3%
-
We hopefully will see a 20-30% jump when the FDA news comes out
-
$MRNA is up over 11%. We should be going up soon or after hour when the FDA approval news comes out
-
Phil I am lmao at you!
-
One thing to consider when buying a stock like NVAX is sentiment - and negative sentiment is at an extreme level - bears are yelling “I told you so” and bulls are cowering (but basically hoping) - so despair reigns right now - FDA approval will come but not on the expresslane like the others were in 2020 - but it will occur - owners have to be patient and really not watch all the up/downticks - let it ride and sleep better - NVAX is a tiny company with growing pains but will be successful - I truly believe that in a year this will be a home run
-
Come to OCGN if you want to get f*** even harder. Lol
-
-
$NVAX Let’s see, how can democrats use this superior vaccine choice to their advantage for midterm elections
We saw a lot of victory laps from Biden’s speech that had no merit. They need this. -
$NVAX Finally Going up on technicals.
-
Is the $1B R&D expenses includes labs and buildings?
-
So I was just looking Novavax’s chart and in mid December it was $217 and dropped all the way down to $73 on January 27th.
What is so interesting is the January 27th is 31 days from the Earnings Release. As you know you need to sell and not buy back in for 30 days in order to claim those losses for tax purposes.
Could this be their plan to avoid Capital Gains Tax all the away back up?
-
So I was just looking Novavax’s chart and in mid December it was $217 and dropped all the way down to $73 on January 27th.
What is so interesting is the January 27th is 31 days from the Earnings Release. As you know you need to sell and not buy back in for 30 days in order to claim those losses for tax purposes.
Could this be their plan to avoid Capital Gains Tax all the away back up?
-
Adding to Lisa’s comment. Recent studies have found that vaccinated people have less capability to produce the nasal protection needed for virus intrusion.
So vaccinated (mRNA study so far), are actually spreading this omricron faster! -
Let’s go to the $85 $85 $85!!
-
Today after hour FDA and Monday first big earnings
-
-
The FDA approval is coming!!
-
Today we will see the $95 and Monday the $120
-
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Why Novavax is Gaining Ground in COVID-19 Vaccine Race
news.google.com • -
Novavax Inc. stock underperforms Monday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Monday when compared to competitors
news.google.com • -
(NVAX) Trading Report
news.google.com • -
Novavax Inc. stock outperforms competitors on strong trading day
news.google.com • -
Should You Buy Novavax Stock After This Regulatory Win?
news.google.com • -
Should You Buy Novavax Stock After This Regulatory Win?
news.google.com • -
Novavax Inc. stock underperforms Thursday when compared to competitors
news.google.com • -
Why Are Novavax Shares Trading Lower Today?
news.google.com •